ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 194 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,306,000 | +217.2% | 30,839 | +391.5% | 0.38% | +228.7% |
| Q2 2018 | $727,000 | -11.3% | 6,275 | -38.1% | 0.12% | -16.1% |
| Q1 2018 | $820,000 | -78.5% | 10,138 | -86.5% | 0.14% | -74.2% |
| Q4 2014 | $3,809,000 | +53.3% | 74,915 | +19.4% | 0.53% | +5.3% |
| Q3 2014 | $2,484,000 | -10.6% | 62,768 | -2.8% | 0.50% | -4.4% |
| Q2 2014 | $2,780,000 | +5.6% | 64,554 | -2.0% | 0.53% | +11.2% |
| Q1 2014 | $2,633,000 | +42.6% | 65,846 | -2.8% | 0.48% | +43.5% |
| Q4 2013 | $1,847,000 | – | 67,708 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |